(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(quinolin-4-yl)methanol

Catalog No. :
ACGVSY375
CAS No. :
485-64-3
Molecular Formula :
C19H24N2O
Molecular Weight :
296.41

IUPAC Name:(R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(quinolin-4-yl)methanol

(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(quinolin-4-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$136.00Login to see priceIn stockIn stock
25g98%$536.00Login to see priceIn stockIn stock
100g98%$1731.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(quinolin-4-yl)methanol
IUPAC Name(R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(quinolin-4-yl)methanol
MDL No.MFCD30489122
Molecular FormulaC19H24N2O
Molecular Weight296.41
SMILESO[C@@H]([C@H]1[N@@]2C[C@H](CC)[C@](CC2)([H])C1)C3=CC=NC4=CC=CC=C34
InChI KeyWFJNHVWTKZUUTR-KODHJQJWSA-N
Synonym(8alpha,9R)-10,11-Dihydrocinchonan-9-ol | E78977 | Hydrocinchonidine | WFJNHVWTKZUUTR-KODHJQJWSA-N | (-)-dihydrocinchonidine | DTXSID001315486 | (3R,8S,9R)-10,11-Dihydrocinchonidine | A,9R)-10,11-dihydro-Cinchonan-9-ol | Q27269695 | (8.ALPHA.,9R)-10,11-DI
CAS No.485-64-3
PubChem CID6914728

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACGVSY375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGVSY375 route product structure diagram
    ACGVSY375485-64-3 In Stock
Inquiry

2. ACGVSY375 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGVSY375 route product structure diagram
    ACGVSY375485-64-3 In Stock
Inquiry

Comments (0)